Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, October 07, 2020
Lonza Bioscience has announced the commercial release of the PyroCell™ MAT System, a sustainable and reliable solution for in vitro pyrogen testing.
read more
Thursday, October 08, 2020
KemPharm has expanded its relationship with Corium through a new consultation services agreement under which KemPharm will provide product development consultation services to Corium.
read more
Thursday, October 08, 2020
ATCC announced a potential 10-year, IDIQ contract award with a ceiling value of $250 million from the BARDA, a division of the Office of the Assistant Secretary for Preparedness and Response with the HHS.
read more
Thursday, October 08, 2020
A partnership between Sandia National Laboratories and BioBright to improve the security of synthetic biology equipment has become more relevant after the United States and others issued warnings that hackers were using the COVID-19 pandemic to ...
read more
Thursday, October 08, 2020
Mustang Bio has acquired rights to SIRION’s LentiBOOST technology for the development of MB-207.
read more
Mapi Pharma announced it will dedicate capacity at its manufacturing facility to support the global effort to provide COVID-19 vaccination to Israel, the EU and globally.
read more
PharmaLex has completed the merger of Biopharma Excellence GmbH.
read more
Oxford Biomedica announced the UK MHRA has issued a Certificate of GMP compliance for the fourth GMP manufacturing suite within the Group’s new Oxbox manufacturing facility.
read more
Exonbio has launched the SARS-CoV-2 Spike recombinant monoclonal antibodies for the global IVD and research communities in support of efforts to combat the pandemic.
read more
CellGenix GmbH has announced the completion of the second phase of their facility expansion.
read more
Centaur will manufacture Vaxart's oral vaccine for COVID-19 and other vaccine candidates.
read more
Intec Pharma has entered into a new research collaboration agreement with MSD, the tradename of Merck & Co. Details of the agreement are confidential.
read more
Argonaut announced the California Department of Public Health, FDB has inspected and approved Argonaut’s new Drug Product Manufacturing facility.
read more
Abzena has invested $60m into a new facility for late phase and commercial cGMP manufacturing.
read more
Kineta Chronic Pain announced the company will extend and expand its research collaboration with Genentech.
read more